Meletios A. Dimopoulos, MD is professor and chairman of the department of clinical therapeutics at the National and Kapodistrian University of Athens (NKUA) School of Medicine, Athens, Greece. He has been elected vice-dean of the medical school for the academic years 2007-11 and dean for the academic years 2011-15. In February 2015 he was elected rector of the University. He obtained his medical degree from the NKUA, completed a residency in internal medicine at the Royal Victoria Hospital, McGill University, Montreal, Canada and a fellowship in hematology/oncology at the University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
Dr Dimopoulos has authored more than 900 publications (June 2018) in peer-reviewed journals, focusing on plasma cell dyscrasias and genitourinary and gynecologic cancers. He has more than 49000 citations and his h-index is 105 (Scopus) and more than 41000 citations and an h-index 97 (ISI).
He is a recipient of the Robert A. Kyle Award for outstanding contributions to Waldenstrom’s macroglobulinemia (May 2003), a recipient of Waldenstrom's award for Myeloma Research of the International Myeloma Society (March 2017), recipient of the CoMy Excellence Award (May 2017). In August 2017 he was given the title "Officier dans l' Ordre des Palmes academiques" (Republique Francaise, Ministere de l' Education Nationale). In May 2018 he was elected as membre associe etranger of the National Academy of Medecine of France.
Dr Dimopoulos served as a minister of health in the transitional government (July and August 2015). Currently he is the chairman of the board of the Foundation of “Julia and Alexander N. Diomedes Botanic Garden” and he is a member of the Board of the National Greek Committee for UNESCO.